Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies
Establishment of parallel work…
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
TAIPEI, Taiwan, February 21, 2…
Shanghai Concord Medical Cancer Center’s Basic Medical Services have been Fully Covered by Medical Insurance
BEIJING, Feb. 20, 2019 /PRNews…
Future of Clinical Laboratories: How to Adapt Your Strategy to the Declining Reimbursements and Be Successful
Transformational Health expert…
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
– Proxy-CRISPR technolog…
